Xiao-xun Xie

Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

OY-TES-1 Splice Variant V5a in Glioma: A Driver of Malignancy and Potential Therapeutic Target.

OY-TES-1 Splice Variant V5a in Glioma: A Driver of Malignancy and Potential Therapeutic Target.

Journal: Current medical science
Published: October 22, 2025

Cancer-testis antigen ACRBP: Cytotoxic response to its HLA-A2 restricted peptide and immune features in ovarian cancer.

Cancer-testis antigen ACRBP: Cytotoxic response to its HLA-A2 restricted peptide and immune features in ovarian cancer.

Journal: Human vaccines & immunotherapeutics
Published: October 16, 2025

ELMOD2 Overexpression Predicts Adverse Outcomes and Regulates Tumor Progression in Gliomas.

ELMOD2 Overexpression Predicts Adverse Outcomes and Regulates Tumor Progression in Gliomas.

Journal: Current medical science
Published: January 24, 2025

Prediction and identification of HLA-A*0201-restricted epitopes from cancer testis antigen CT23.

Prediction and identification of HLA-A*0201-restricted epitopes from cancer testis antigen CT23.

Journal: Human vaccines & immunotherapeutics
Published: December 15, 2023

Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma.

Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma.

Journal: Frontiers in oncology
Published: February 11, 2022

High Expression of Fibronectin 1 Predicts a Poor Prognosis in Glioblastoma.

High Expression of Fibronectin 1 Predicts a Poor Prognosis in Glioblastoma.

Journal: Current medical science
Published: February 11, 2022

Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.

Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.

Journal: Current medical science
Published: November 14, 2021

FMR1NB Involved in Glioma Tumorigenesis Is a Promising Target for Prognosis and Therapy.

FMR1NB Involved in Glioma Tumorigenesis Is a Promising Target for Prognosis and Therapy.

Journal: Current medical science
Published: March 30, 2021

Identification of Dysregulated microRNAs in Glioma Using RNA-sequencing.

Identification of Dysregulated microRNAs in Glioma Using RNA-sequencing.

Journal: Current medical science
Published: November 03, 2020

Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma.

Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma.

Journal: American journal of translational research
Published: August 15, 2020

Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma.

Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma.

Journal: Current medical science
Published: July 17, 2019

Involvement of X-chromosome Reactivation in Augmenting Cancer Testis Antigens Expression: A Hypothesis.

Involvement of X-chromosome Reactivation in Augmenting Cancer Testis Antigens Expression: A Hypothesis.

Journal: Current medical science
Published: October 09, 2017
Showing 1-12 of 23

Last Updated: 09/26/2026